Difference between revisions of "The Regents of the University of California patent applications published on November 30th, 2023"
Jump to navigation
Jump to search
Wikipatents (talk | contribs) |
Wikipatents (talk | contribs) (Creating a new page) |
||
Line 1: | Line 1: | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
==Patent applications for The Regents of the University of California on November 30th, 2023== | ==Patent applications for The Regents of the University of California on November 30th, 2023== | ||
Line 35: | Line 8: | ||
Mihaela Balu | Mihaela Balu | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS ([[US Patent Application 18028311. COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS simplified abstract|18028311]])=== | ===COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS ([[US Patent Application 18028311. COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS simplified abstract|18028311]])=== | ||
Line 52: | Line 16: | ||
Daniel L. KAUFMAN | Daniel L. KAUFMAN | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS ([[US Patent Application 18178266. CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS simplified abstract|18178266]])=== | ===CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS ([[US Patent Application 18178266. CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS simplified abstract|18178266]])=== | ||
Line 71: | Line 24: | ||
Varghese John | Varghese John | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS ([[US Patent Application 18034037. ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS simplified abstract|18034037]])=== | ===ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS ([[US Patent Application 18034037. ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS simplified abstract|18034037]])=== | ||
Line 88: | Line 32: | ||
Qizhi TANG | Qizhi TANG | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===ATTENUATED CANCER CELLS AND METHODS RELATED THERETO ([[US Patent Application 18032932. ATTENUATED CANCER CELLS AND METHODS RELATED THERETO simplified abstract|18032932]])=== | ===ATTENUATED CANCER CELLS AND METHODS RELATED THERETO ([[US Patent Application 18032932. ATTENUATED CANCER CELLS AND METHODS RELATED THERETO simplified abstract|18032932]])=== | ||
Line 106: | Line 40: | ||
Zhen Gu | Zhen Gu | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING ([[US Patent Application 18315370. MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING simplified abstract|18315370]])=== | ===MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING ([[US Patent Application 18315370. MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING simplified abstract|18315370]])=== | ||
Line 125: | Line 48: | ||
Song Li | Song Li | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE ([[US Patent Application 18311630. APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE simplified abstract|18311630]])=== | ===APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE ([[US Patent Application 18311630. APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE simplified abstract|18311630]])=== | ||
Line 144: | Line 56: | ||
Jennifer Lu | Jennifer Lu | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE ([[US Patent Application 18248291. TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE simplified abstract|18248291]])=== | ===TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE ([[US Patent Application 18248291. TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE simplified abstract|18248291]])=== | ||
Line 164: | Line 64: | ||
Yoshihiro Izumiya | Yoshihiro Izumiya | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS ([[US Patent Application 18028345. MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS simplified abstract|18028345]])=== | ===MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS ([[US Patent Application 18028345. MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS simplified abstract|18028345]])=== | ||
Line 181: | Line 72: | ||
Daniel L. COX | Daniel L. COX | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===ANTI-CD46 ANTIBODIES AND METHODS OF USE ([[US Patent Application 17815514. ANTI-CD46 ANTIBODIES AND METHODS OF USE simplified abstract|17815514]])=== | ===ANTI-CD46 ANTIBODIES AND METHODS OF USE ([[US Patent Application 17815514. ANTI-CD46 ANTIBODIES AND METHODS OF USE simplified abstract|17815514]])=== | ||
Line 201: | Line 80: | ||
Bin Liu | Bin Liu | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH ([[US Patent Application 18247960. MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH simplified abstract|18247960]])=== | ===MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH ([[US Patent Application 18247960. MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH simplified abstract|18247960]])=== | ||
Line 218: | Line 88: | ||
Yadong Yin | Yadong Yin | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA ([[US Patent Application 18333231. BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA simplified abstract|18333231]])=== | ===BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA ([[US Patent Application 18333231. BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA simplified abstract|18333231]])=== | ||
Line 238: | Line 96: | ||
Terry W. Osborn | Terry W. Osborn | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME ([[US Patent Application 18449110. PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME simplified abstract|18449110]])=== | ===PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME ([[US Patent Application 18449110. PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME simplified abstract|18449110]])=== | ||
Line 256: | Line 104: | ||
Shaowei Chen | Shaowei Chen | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE ([[US Patent Application 18301825. ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE simplified abstract|18301825]])=== | ===ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE ([[US Patent Application 18301825. ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE simplified abstract|18301825]])=== | ||
Line 280: | Line 112: | ||
Raymond Mitchell Spearrin | Raymond Mitchell Spearrin | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===NONIMAGING ASYMMETRIC SHADELESS COLLECTOR ([[US Patent Application 18030729. NONIMAGING ASYMMETRIC SHADELESS COLLECTOR simplified abstract|18030729]])=== | ===NONIMAGING ASYMMETRIC SHADELESS COLLECTOR ([[US Patent Application 18030729. NONIMAGING ASYMMETRIC SHADELESS COLLECTOR simplified abstract|18030729]])=== | ||
Line 299: | Line 120: | ||
Bennett WIDYOLAR | Bennett WIDYOLAR | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===IMAGE-BASED CELL SORTING SYSTEMS AND METHODS ([[US Patent Application 18295244. IMAGE-BASED CELL SORTING SYSTEMS AND METHODS simplified abstract|18295244]])=== | ===IMAGE-BASED CELL SORTING SYSTEMS AND METHODS ([[US Patent Application 18295244. IMAGE-BASED CELL SORTING SYSTEMS AND METHODS simplified abstract|18295244]])=== | ||
Line 322: | Line 128: | ||
Yu-Hwa Lo | Yu-Hwa Lo | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME ([[US Patent Application 18201886. BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME simplified abstract|18201886]])=== | ===BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME ([[US Patent Application 18201886. BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME simplified abstract|18201886]])=== | ||
Line 343: | Line 136: | ||
Marco Rolandi | Marco Rolandi | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging ([[US Patent Application 18363714. Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging simplified abstract|18363714]])=== | ===Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging ([[US Patent Application 18363714. Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging simplified abstract|18363714]])=== | ||
Line 363: | Line 144: | ||
Christopher J. Chang | Christopher J. Chang | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS ([[US Patent Application 18248934. GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS simplified abstract|18248934]])=== | ===GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS ([[US Patent Application 18248934. GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS simplified abstract|18248934]])=== | ||
Line 382: | Line 152: | ||
Chunyang DONG | Chunyang DONG | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===QUANTUM WRAPPER NETWORKING ([[US Patent Application 18248931. QUANTUM WRAPPER NETWORKING simplified abstract|18248931]])=== | ===QUANTUM WRAPPER NETWORKING ([[US Patent Application 18248931. QUANTUM WRAPPER NETWORKING simplified abstract|18248931]])=== | ||
Line 400: | Line 159: | ||
Sung-Joo Ben Yoo | Sung-Joo Ben Yoo | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− |
Revision as of 04:39, 5 December 2023
Contents
- 1 Patent applications for The Regents of the University of California on November 30th, 2023
- 1.1 METHODS FOR NON-INVASIVE, LABEL-FREE IMAGING OF CELLULAR IMMUNE RESPONSE IN HUMAN SKIN USING A NONLINEAR OPTICAL MICROSCOPY IMAGING SYSTEM (18202874)
- 1.2 COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS (18028311)
- 1.3 CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS (18178266)
- 1.4 ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS (18034037)
- 1.5 ATTENUATED CANCER CELLS AND METHODS RELATED THERETO (18032932)
- 1.6 MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING (18315370)
- 1.7 APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE (18311630)
- 1.8 TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE (18248291)
- 1.9 MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS (18028345)
- 1.10 ANTI-CD46 ANTIBODIES AND METHODS OF USE (17815514)
- 1.11 MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH (18247960)
- 1.12 BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA (18333231)
- 1.13 PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME (18449110)
- 1.14 ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE (18301825)
- 1.15 NONIMAGING ASYMMETRIC SHADELESS COLLECTOR (18030729)
- 1.16 IMAGE-BASED CELL SORTING SYSTEMS AND METHODS (18295244)
- 1.17 BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME (18201886)
- 1.18 Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging (18363714)
- 1.19 GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS (18248934)
- 1.20 QUANTUM WRAPPER NETWORKING (18248931)
Patent applications for The Regents of the University of California on November 30th, 2023
METHODS FOR NON-INVASIVE, LABEL-FREE IMAGING OF CELLULAR IMMUNE RESPONSE IN HUMAN SKIN USING A NONLINEAR OPTICAL MICROSCOPY IMAGING SYSTEM (18202874)
Main Inventor
Mihaela Balu
COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS (18028311)
Main Inventor
Daniel L. KAUFMAN
CONJOINT THERAPIES FOR TREATING VIRAL INFECTIONS (18178266)
Main Inventor
Varghese John
ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS (18034037)
Main Inventor
Qizhi TANG
ATTENUATED CANCER CELLS AND METHODS RELATED THERETO (18032932)
Main Inventor
Zhen Gu
MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING (18315370)
Main Inventor
Song Li
APPARATUS AND METHODS FOR METHYL MERCURY DETECTION AND CAPTURE (18311630)
Main Inventor
Jennifer Lu
TRANSCRIPTION ACTIVE COMPLEX TARGETING CANCER DRUG FROM VIRAL PROTEIN SEQUENCE (18248291)
Main Inventor
Yoshihiro Izumiya
MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS (18028345)
Main Inventor
Daniel L. COX
ANTI-CD46 ANTIBODIES AND METHODS OF USE (17815514)
Main Inventor
Bin Liu
MAGNETICALLY TUNABLE PLASMON COUPLING OF NANOSHELLS ENABLED BY SPACE-FREE CONFINED GROWTH (18247960)
Main Inventor
Yadong Yin
BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA (18333231)
Main Inventor
Terry W. Osborn
PLATINUM OXIDE NANOPARTICLES FOR ELECTROCHEMICAL HYDROGEN EVOLUTION AND METHODS FOR MAKING AND USING THE SAME (18449110)
Main Inventor
Shaowei Chen
ADAPTIVE ANY-FUEL CAMLESS RECIPROCATING ENGINE (18301825)
Main Inventor
Raymond Mitchell Spearrin
NONIMAGING ASYMMETRIC SHADELESS COLLECTOR (18030729)
Main Inventor
Bennett WIDYOLAR
IMAGE-BASED CELL SORTING SYSTEMS AND METHODS (18295244)
Main Inventor
Yu-Hwa Lo
BIOMIMETIC LEAF WETNESS SENSOR AND METHOD OF MANUFACTURE OF THE SAME (18201886)
Main Inventor
Marco Rolandi
Tandem Activity-Based Sensing and Labeling Strategy for Reactive Oxygen Species Imaging (18363714)
Main Inventor
Christopher J. Chang
GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS (18248934)
Main Inventor
Chunyang DONG
QUANTUM WRAPPER NETWORKING (18248931)
Main Inventor
Sung-Joo Ben Yoo